Grant et al. [21] suggested that variants in TCF7L2 affect an individual’s susceptibility to T2DM through impaired transcriptional regulation of the insulinotropic hormone GLP1-1, encoded by GCG and expressed in the brain and gut. The gene discussed is TCF7L2; the disease is type 2 diabetes mellitus.